Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New strategies for treating AIDS

P A Sandstrom1, T M Folks

  • 1Retrovirus Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans.

Journal of clinical microbiology·2004
Same author

Simian foamy virus infection in a blood donor.

Transfusion·2002
Same author

Chronic immune stimulation accelerates SIV-induced disease progression.

Journal of medical primatology·2002
Same author

Facilitated detection of adventitious agents using genetically engineered cell lines.

Developments in biologicals·2002
Same author

Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Clinical microbiology reviews·2001
Same author

Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1.

AIDS research and human retroviruses·2001

Two new human immunodeficiency virus type 1 (HIV-1) treatments show promise. One targets zinc finger structures in HIV-1, while the other uses a reverse transcriptase inhibitor for post-exposure prophylaxis.

Area of Science:

  • Virology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Effective management of HIV-1 infection remains challenging due to rapid drug resistance.
  • Current antiretroviral therapies face limitations in long-term efficacy.

Purpose of the Study:

  • To report on two novel therapeutic strategies for combating HIV-1 infection.
  • To explore new targets for antiretroviral drug development.
  • To assess the potential of post-exposure prophylaxis against HIV-1.

Main Methods:

  • Investigated retroviral-type zinc finger structures within the HIV-1 nucleocapsid protein as potential drug targets.
  • Evaluated the efficacy of (R)-9-(2-phosphonylmethoxypropyl) adenine, a reverse transcriptase inhibitor, as post-exposure prophylaxis.

Related Experiment Videos

Main Results:

  • Identified HIV-1 nucleocapsid protein's zinc finger structures as viable targets for antiretroviral drug design.
  • Demonstrated the feasibility of using (R)-9-(2-phosphonylmethoxypropyl) adenine to block HIV-1 infection post-exposure.

Conclusions:

  • These findings present two promising avenues for advancing HIV-1 treatment and prevention.
  • Targeting viral structural proteins and utilizing novel prophylactic agents offer new hope in managing HIV-1 infection.